405 results on '"MEN who have sex with men"'
Search Results
2. Expanding the Evidence Base for Improving Sexual Health Among Transgender Communities: The Importance of Rigorous Epidemiologic Studies.
- Author
-
Rushmore, Julie, Learner, Emily R, and Bernstein, Kyle T
- Subjects
- *
TRANSGENDER communities , *HEALTH of transgender people , *SEXUAL health , *HIV seroconversion , *HIV infections , *IMPOTENCE , *MEN who have sex with men - Abstract
The article discusses the importance of rigorous epidemiologic studies in improving sexual health among transgender communities. It highlights the disparities in sexual health outcomes between transgender and cisgender populations and the lack of research in this area. The article focuses on a study called The Leading Innovation for Transgender Women's Health and Empowerment (LITE), which investigates the prevalence and factors associated with bacterial sexually transmitted infections (STIs) among transgender women in multiple cities across the US. The study found a high prevalence of bacterial STIs among transgender women, with differences based on HIV status. The article emphasizes the need for tailored interventions to address sexual health inequities and the importance of collecting accurate data to inform prevention programs. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
3. Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price.
- Author
-
Amick, Alyssa K, Eskibozkurt, G Ege, Hosek, Sybil G, Flanagan, Clare F, Landovitz, Raphael J, Jin, Elena Y, Wilson, Craig M, Freedberg, Kenneth A, Weinstein, Milton C, Kazemian, Pooyan, Paltiel, A David, Ciaranello, Andrea L, and Neilan, Anne M
- Subjects
- *
HIV infection epidemiology , *HIV prevention , *ORAL drug administration , *TENOFOVIR , *COST control , *MEDICAL screening , *ANTIRETROVIRAL agents , *DISEASE incidence , *MEDICAL care costs , *PRE-exposure prophylaxis , *AIDS serodiagnosis , *COMPARATIVE studies , *GENERIC drugs , *DESCRIPTIVE statistics , *COST effectiveness , *RESEARCH funding , *MEN who have sex with men , *EMTRICITABINE , *QUALITY-adjusted life years - Abstract
Background Adherence and retention concerns raise questions about the effectiveness and cost-effectiveness of oral HIV pre-exposure prophylaxis (PrEP) in young men who have sex with men (YMSM). Methods Using an adolescent-focused simulation model, we compared annual HIV screening alone with tenofovir disoproxil fumarate/emtricitabine–based oral PrEP with every 3-month HIV screening in YMSM (aged 15–24) at increased risk of HIV. Data derived from published sources included: age-stratified HIV incidence/100 person-years (PY) on- or off-PrEP (0.6–10.1 or 0.4–6.4), PrEP retention at 6 years (28%), transmissions by HIV RNA level (0.0–78.4/100PY) and annual costs of antiretroviral therapy ($32 000–69 000), HIV care ($3100–34 600), and PrEP program/generic drug ($900/360). Outcomes included transmissions (percent of cohort infected), quality-adjusted life-years (QALYs), costs ($), and incremental cost-effectiveness ratios ($/QALY). We explored the sensitivity of findings to variation in HIV incidence and drug prices. Results Compared with annual screening alone, PrEP would increase QALYs (9.58 to 9.67), reduce new infections (37% to 30%), and decrease costs (by $5000) over 10 years. PrEP would remain cost-saving for HIV incidence off-PrEP ≥5.1/100PY or annual PrEP price ≤$1200. Over a lifetime horizon, PrEP would be cost-saving for HIV incidence off-PrEP ≥1.0/100PY, across all retention assumptions examined. PrEP would not be cost-effective at HIV incidence ≤0.1/100PY, regardless of drug price, due to programmatic costs. Conclusions In US YMSM at increased risk of HIV, generic oral PrEP and every-3-month screening would be cost-saving compared with annual screening alone, even with high discontinuation and low adherence, over a range of HIV incidences. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986–2020.
- Author
-
Nduva, George M, Otieno, Frederick, Kimani, Joshua, Sein, Yiakon, Arimide, Dawit A, Mckinnon, Lyle R, Cholette, Francois, Lawrence, Morris K, Majiwa, Maxwell, Masika, Moses, Mutua, Gaudensia, Anzala, Omu, Graham, Susan M, Gelmon, Larry, Price, Matt A, Smith, Adrian D, Bailey, Robert C, Medstrand, Patrik, Sanders, Eduard J, and Esbjörnsson, Joakim
- Subjects
- *
RALTEGRAVIR , *INFECTIOUS disease transmission , *DRUG resistance , *HIV , *REVERSE transcriptase inhibitors , *INTEGRASE inhibitors - Abstract
Background Evidence on the distribution of pre-treatment HIV-1 drug resistance (HIVDR) among risk groups is limited in Africa. We assessed the prevalence, trends and transmission dynamics of pre-treatment HIVDR within and between MSM, people who inject drugs (PWID), female sex workers (FSWs), heterosexuals (HETs) and perinatally infected children in Kenya. Methods HIV-1 partial pol sequences from antiretroviral-naive individuals collected from multiple sources between 1986 and 2020 were used. Pre-treatment reverse transcriptase inhibitor (RTI), PI and integrase inhibitor (INSTI) mutations were assessed using the Stanford HIVDR database. Phylogenetic methods were used to determine and date transmission clusters. Results Of 3567 sequences analysed, 550 (15.4%, 95% CI: 14.2–16.6) had at least one pre-treatment HIVDR mutation, which was most prevalent amongst children (41.3%), followed by PWID (31.0%), MSM (19.9%), FSWs (15.1%) and HETs (13.9%). Overall, pre-treatment HIVDR increased consistently, from 6.9% (before 2005) to 24.2% (2016–20). Among HETs, pre-treatment HIVDR increased from 6.6% (before 2005) to 20.2% (2011–15), but dropped to 6.5% (2016–20). Additionally, 32 clusters with shared pre-treatment HIVDR mutations were identified. The majority of clusters had R0 ≥ 1.0, indicating ongoing transmissions. The largest was a K103N cluster involving 16 MSM sequences sampled between 2010 and 2017, with an estimated time to the most recent common ancestor (tMRCA) of 2005 [95% higher posterior density (HPD), 2000–08], indicating propagation over 12 years. Conclusions Compared to HETs, children and key populations had higher levels of pre-treatment HIVDR. Introduction of INSTIs after 2017 may have abrogated the increase in pre-treatment RTI mutations, albeit in the HET population only. Taken together, our findings underscore the need for targeted efforts towards equitable access to ART for children and key populations in Kenya. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Impact of participation as a peer change agent on peer change agents themselves: a quantitative study of a peer-led, social media-based PrEP promotion intervention.
- Author
-
Cooper, Spring C, Santella, Anthony J, Caines, Matthew, Rojanaworarit, Chanapong, and Hernandez, Alex
- Subjects
HIV prevention ,PILOT projects ,STATISTICS ,PROFESSIONAL practice ,INTERNET ,SOCIAL media ,PEER counseling ,MEDICAL care ,QUANTITATIVE research ,PRE-exposure prophylaxis ,SELF-efficacy ,PRE-tests & post-tests ,RESEARCH funding ,MEN who have sex with men ,DATA analysis ,HEALTH promotion - Abstract
Despite the adoption of pre-exposure prophylaxis (PrEP) as a crucial HIV intervention, uptake remains suboptimal among men who have sex with men, a sexual minority group, due to barriers like cost and stigma. Peer change agents (PCAs) disseminate PrEP information within their social networks. This study explores the reciprocal effects of an online community-based participatory intervention on PCAs, focusing on their transformed PrEP uptake perceptions—leadership efficacy, social network dynamics, attitudes, perceived benefits and barriers and self-efficacy. Leveraging insights from the PrEP Chicago Study, our research addresses a key gap in community-based participatory interventions for PrEP uptake: the transformative experiences and perception shifts of PCAs involved in these interventions. We engaged 20 men who have sex with men, aged 18–45, as PCAs in a one-group pretest–posttest design intervention, which disseminated PrEP communications within their preferred online networks. We utilized the PrEP Chicago Study's 45 Likert items, tailored to reveal the PCAs' transformative potential. Data on PrEP uptake perceptions, sociodemographics and social media use were captured and analyzed using the Wilcoxon matched-pairs signed-rank test, a nonparametric method. PCAs demonstrated significant changes in their PrEP uptake perceptions, including leadership capacity, social network dynamics, attitudes toward PrEP, perceived benefits, barriers and self-efficacy. Our intervention highlights the reciprocal transformation PCAs undergo when disseminating PrEP information. This study adds a new dimension to community-based PrEP interventions and underscores the need for continued refinement of peer-led strategies to optimize the transformative potential of PCAs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Causal Effects of Stochastic PrEP Interventions on HIV Incidence Among Men Who Have Sex With Men.
- Author
-
Sewak, Ainesh, Lodi, Sara, Li, Xiaojuan, Shu, Di, Wen, Lan, Mayer, Kenneth H, Krakower, Douglas S, Young, Jessica G, and Marcus, Julia L
- Subjects
- *
HIV infection epidemiology , *PREVENTION of infectious disease transmission , *HIV infection prognosis , *HIV prevention , *HIV-positive persons , *DISEASE incidence , *ANTIRETROVIRAL agents , *COMMUNITY health services , *PRE-exposure prophylaxis , *HOMOSEXUALITY , *RISK assessment , *SEXUAL minorities , *ATTRIBUTION (Social psychology) , *RESEARCH funding , *DESCRIPTIVE statistics , *MEN who have sex with men , *ELECTRONIC health records , *LONGITUDINAL method , *PROBABILITY theory - Abstract
Antiretroviral preexposure prophylaxis (PrEP) is highly effective in preventing human immunodeficiency virus (HIV) infection, but uptake has been limited and inequitable. Although interventions to increase PrEP uptake are being evaluated in clinical trials among men who have sex with men (MSM), those trials cannot evaluate effects on HIV incidence. Estimates from observational studies of the causal effects of PrEP-uptake interventions on HIV incidence can inform decisions about intervention scale-up. We used longitudinal electronic health record data from HIV-negative MSM accessing care at Fenway Health, a community health center in Boston, Massachusetts, from January 2012 through February 2018, with 2 years of follow-up. We considered stochastic interventions that increased the chance of initiating PrEP in several high-priority subgroups. We estimated the effects of these interventions on population-level HIV incidence using a novel inverse-probability weighted estimator of the generalized g-formula, adjusting for baseline and time-varying confounders. Our results suggest that even modest increases in PrEP initiation in high-priority subgroups of MSM could meaningfully reduce HIV incidence in the overall population of MSM. Interventions tailored to Black and Latino MSM should be prioritized to maximize equity and impact. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Risk of hepatocellular carcinoma in people with HIV in the United States, 2001-2019.
- Author
-
McGee-Avila, Jennifer K, Argirion, Ilona, Engels, Eric A, O'Brien, Thomas R, Horner, Marie-Josèphe, Qiao, Baozhen, Monterosso, Analise, Luo, Qianlai, and Shiels, Meredith S
- Subjects
- *
HEPATITIS C , *HEPATOCELLULAR carcinoma , *HIV-positive persons , *HEPATITIS B virus , *HEPATITIS C virus , *DISEASE prevalence - Abstract
Background People with HIV have higher risk of hepatocellular carcinoma than the general population, partly because of higher prevalence of coinfection with hepatitis B virus (HBV) or hepatitis C virus (HCV). Methods We calculated standardized incidence ratios for hepatocellular carcinoma in people with HIV by comparing rates from people with HIV in the HIV/AIDS Cancer Match Study, a population-based HIV and cancer registry linkage, to those in the general population. We used multivariable Poisson regression to estimate adjusted incidence rate ratios among people with HIV and linked the Texas HIV registry with medical claims data to estimate adjusted odds ratios (AORs) of HBV and HCV in hepatocellular carcinoma patients with logistic regression. Results Compared with the general population, hepatocellular carcinoma rates in people with HIV were elevated 2.79-fold (n = 1736; 95% confidence interval [CI] = 2.66 to 2.92). Hepatocellular carcinoma rates decreased statistically significantly from 2001-2004 to 2015-2019 (P < .001). Compared with men who have sex with men, hepatocellular carcinoma risk was elevated 4.28-fold among men who injected drugs (95% CI = 3.72 to 4.93) and 1.83-fold among women who injected drugs (95% CI = 1.49 to 2.26). In Texas, 146 hepatocellular carcinoma cases among people with HIV were linked to claims data: 25% HBV positive, 59% HCV positive, and 13% coinfected with HBV and HCV. Compared with men who had sex with men, people who inject drugs had 82% decreased odds of HBV (AOR = 0.18, 95% CI = 0.05 to 0.63) and 2 times the odds of HCV (AOR = 20.4, 95% CI = 3.32 to 125.3). Conclusions During 2001-2019, hepatocellular carcinoma risk declined among people with HIV, though rates remain statistically significantly elevated compared with the general population, particularly among people who inject drugs. Prevention and treatment of HBV/HCV are needed to reduce hepatocellular carcinoma risk among people with HIV. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Sexually Transmitted Dermatophytes Can Cause Severe Infection Among Men who Have Sex With Men as Tinea Genitalis.
- Author
-
Chromy, David, Osmers, Anthea-Margaux, Bauer, Wolfgang Michael, Touzeau-Roemer, Veronique, Borst, Carina, Esser, Stefan, Weninger, Wolfgang, Willinger, Birgit, and Grabmeier-Pfistershammer, Katharina
- Subjects
- *
SEXUALLY transmitted diseases , *HIV seroconversion , *DERMATOPHYTES , *HIV infections , *RINGWORM , *PRE-exposure prophylaxis , *SEXUAL intercourse - Abstract
Very limited data on tinea genitalis, a potentially severe dermatophytosis transmitted during sexual intercourse affecting the genital area, suggest its potential to cause outbreaks. Thus, we investigated genital dermatophyte infections at an HIV/sexually transmitted infection clinic and identified 17 men who have sex with men (all people with HIV or pre-exposure prophylaxis users) diagnosed with tinea genitalis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. HIV pre-exposure prophylaxis: It is time to consider harm reduction care for adolescents in Canada.
- Author
-
Leonard, Sean, Sotindjo, Tatiana, Brophy, Jason, Tan, Darrell H S, and Nashid, Nancy
- Subjects
- *
HIV prevention , *MEDICAL screening , *HARM reduction , *PRE-exposure prophylaxis , *TREATMENT effectiveness , *CASE studies , *MEN who have sex with men - Abstract
Youth (aged 15 to 29 years) account for one quarter of new HIV cases in Canada. Of those, men-who-have-sex-with-men make up one third to one half of new cases in that age range. Moreover, Indigenous youth are over-represented in the proportion of new cases. The use of emtricitabine/tenofovir disoproxil fumarate as pre-exposure prophylaxis (PrEP) significantly reduces the risk of HIV acquisition in adults. Its use was expanded to include youth over 35 kg by the U.S. Food and Drug Administration in 2018. However, PrEP uptake remains low among adolescents. Prescriber-identified barriers include lack of experience, concerns about safety, unfamiliarity with follow-up guidelines, and costs. This article provides an overview of PrEP for youth in Canada, and its associated safety and side effect profiles. Hypothetical case vignettes highlight some of the many demographics of youth who could benefit from PrEP. We present a novel flow diagram that explains the baseline workup, prescribing guidelines, and follow-up recommendations in the Canadian context. Additional counselling points highlight some of the key discussions that should be elicited when prescribing PrEP. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. HCV Microelimination for High-risk Special Populations.
- Author
-
Huang, Chung-Feng, Chen, Guan-Jhou, Hung, Chien-Ching, and Yu, Ming-Lung
- Subjects
- *
HIV , *HEPATITIS C virus , *VIRAL hepatitis , *DRUG abuse - Abstract
The World Health Organization has set tremendous goals to eliminate viral hepatitis by 2030. However, most countries are currently off the track for achieving these goals. Microelimination is a more effective and practical approach that breaks down national elimination targets into goals for smaller and more manageable key populations. These key populations share the characteristics of being highly prevalent for and vulnerable to hepatitis C virus (HCV) infection. Microelimination allows for identifying HCV-infected people and linking them to care more cost-effectively and efficiently. In this review, we discuss the current obstacles to and progress in HCV microelimination in special populations, including uremic patients undergoing hemodialysis, people who inject drugs, incarcerated people, people living in hyperendemic areas, men who have sex with men with or without human immunodeficiency virus (HIV) infection, transgender and gender-diverse populations, and sex workers. Scaling up testing and treatment uptake to achieve HCV microelimination may facilitate global HCV elimination by 2030. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Direct-Acting Antiviral Therapy for Treatment of Acute and Recent Hepatitis C Virus Infection: A Narrative Review.
- Author
-
Martinello, Marianne, Naggie, Susanna, Rockstroh, Juergen Kurt, and Matthews, Gail V
- Subjects
- *
PROTEINS , *COMBINATION drug therapy , *ANTIVIRAL agents , *HEPATITIS C , *HEPATITIS viruses , *NUCLEOTIDES , *GENOTYPES , *DRUG resistance in microorganisms , *MEN who have sex with men - Abstract
Following the discovery of hepatitis C virus (HCV) in 1989, 3 decades of basic, translational, and clinical research culminated in the development of direct-acting antiviral (DAA) therapy—curative oral treatment for HCV infection. The availability of DAA therapy revolutionized HCV clinical management, including acute (duration of infection <6 mo) and recent (duration of infection <12 mo) infection. Several DAA regimens, including the contemporary pan-genotypic combinations of sofosbuvir-velpatasvir and glecaprevir-pibrentasvir, have been shown to be safe and effective among people with acute and recent HCV infection, highlighting their potential in an HCV controlled human infection model. This article describes the natural history and management of acute and recent HCV infection in the era of DAA therapy and outlines a strategy for use of DAA therapies in the setting of an HCV controlled human infection model. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Human Immunodeficiency Virus Seroconversion Among Men Who Have Sex With Men Who Use Event-Driven or Daily Oral Pre-Exposure Prophylaxis (CohMSM-PrEP): A Multi-Country Demonstration Study From West Africa.
- Author
-
Laurent, Christian, Yaya, Issifou, Cuer, Benjamin, Sagaon-Teyssier, Luis, Mensah, Ephrem, Dah, Ter Tiero Elias, Coulibaly, Alou, Kouamé, Malan Jean-Baptiste, Peytavin, Gilles, Serrano, Laetitia, Eubanks, August, Traoré, Issa, Diallo, Fodié, Riegel, Lucas, Castro, Daniela Rojas, Dagnra, Claver A, Anoma, Camille, Vuylsteke, Bea, Keita, Bintou Dembélé, and Spire, Bruno
- Subjects
- *
HIV infection epidemiology , *SOCIAL determinants of health , *CONFIDENCE intervals , *ORAL drug administration , *MULTIVARIATE analysis , *SEROCONVERSION , *REGRESSION analysis , *DISEASE incidence , *PRE-exposure prophylaxis , *DESCRIPTIVE statistics , *RESEARCH funding , *MEN who have sex with men , *SOCIODEMOGRAPHIC factors , *DATA analysis software , *HIV , *LONGITUDINAL method , *POISSON distribution - Abstract
Background Data on human immunodeficiency virus (HIV) seroconversion among men who have sex with men (MSM) using pre-exposure prophylaxis (PrEP) in West Africa are needed. This study aimed to document HIV seroconversion and associated determinants, PrEP adherence, plasma drug concentrations, and HIV drug resistance in MSM using event-driven or daily PrEP in Burkina Faso, Côte d'Ivoire, Mali, and Togo. Methods A prospective cohort study was conducted in 2017–2021 among HIV-seronegative MSM aged 18 or over who were at high risk of HIV infection. Participants could choose between event-driven and daily PrEP, switch regimens, and discontinue or restart PrEP. The determinants of HIV incidence were investigated using a multivariate mixed-effects Poisson regression analysis. Results A total of 647 participants were followed for a total time of 1229.3 person-years. Of 5371 visits, event-driven PrEP was chosen in 3873 (72.1%), and daily PrEP in 1400 (26.1%). HIV incidence was 2.4 per 100 person-years (95% confidence interval [CI] 1.5–3.6) for event-driven PrEP, and 0.6 per 100 person-years (95% CI.1–2.3) for daily PrEP (adjusted incidence rate ratio 4.40, 95% CI 1.00–19.36, P =.050). Adequate adherence was lower with event-driven than daily PrEP (44.3% vs 74.9%, P <.001). Plasma drug concentrations were undetectable in 92 (97.9%) of the 94 measures taken for 23 participants who seroconverted. Only 1 participant had resistance to PrEP drugs. Conclusions HIV seroconversions mainly occurred in participants who chose event-driven PrEP. The study's data highlighted major difficulties with adherence to this regimen. Improving adherence to event-driven PrEP constitutes a major research and public health priority in this context. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. A Randomized Clinical Trial of 1-Dose vs Accelerated 2-Dose Schedule for Hepatitis A Virus (HAV) Revaccination Among People With Human Immunodeficiency Virus Who Were Nonresponders or Had Seroreversion After Primary HAV Vaccination.
- Author
-
Chen, Guan-Jhou, Sun, Hsin-Yun, Lin, Kuan-Yin, Hsieh, Szu-Min, Chuang, Yu-Chung, Liu, Wang-Da, Huang, Yu-Shan, Pan, Sung-Ching, Wu, Un-In, Cheng, Aristine, Huang, Yi-Chia, Wu, Cheng-Hsin, Su, Yi-Ching, Liu, Wen-Chun, Chang, Sui-Yuan, and Hung, Chien-Ching
- Subjects
- *
HIV seronegativity , *IMMUNIZATION , *HEPATITIS A vaccines , *RANDOMIZED controlled trials , *DESCRIPTIVE statistics , *RESEARCH funding , *STATISTICAL sampling , *HIV - Abstract
Background For people with human immunodeficiency virus (PWH) who have no serological responses to their primary hepatitis A virus (HAV) vaccination or have seroreversion after successful primary vaccination, the optimal revaccination strategy remains unclear. Methods In this open-label, randomized clinical trial, PWH who tested negative for anti-HAV antibodies after receiving a standard 2-dose series of primary HAV vaccination were enrolled and assigned in a 1:1 ratio to receive either 1 dose (the 1-dose group) or 2 doses of HAV vaccine administered 4 weeks apart (the 2-dose group). Serological response rates and anti-HAV antibody titers were compared at weeks 24 and 48. Results Of the 153 participants (77 in the 1-dose group and 76 in the 2-dose group), the overall serological response rates at week 48 after revaccination were similar between the 2 groups (2- vs 1-dose, 80.2% vs 71.4%, P =.20). However, anti-HAV antibody titers were consistently higher in the 2-dose group than in the 1-dose group. In subgroup analysis, PWH who were nonresponders to primary HAV vaccination were significantly more likely to mount a serological response after 2-dose HAV revaccination (68.4% vs 44.1%, P =.038). No severe adverse events were reported throughout the study. Conclusions Two-dose HAV revaccination administered 4 weeks apart yielded similar serological responses as 1-dose revaccination among PWH who were nonresponders or had seroreversion after primary HAV vaccination. The 2-dose revaccination schedule generated significantly higher anti-HAV antibody titers and was more likely to elicit serological responses at week 48 among PWH who were nonresponders to primary HAV vaccination. Clinical Trials Registration. NCT03855176. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
14. Human Papillomavirus-Associated Anal Cancer Incidence and Burden Among US Men, According to Sexual Orientation, Human Immunodeficiency Virus Status, and Age.
- Author
-
Deshmukh, Ashish A, Damgacioglu, Haluk, Georges, Damien, Sonawane, Kalyani, and Clifford, Gary M
- Subjects
- *
PAPILLOMAVIRUSES , *SEXUAL orientation , *HUMAN sexuality , *HEALTH status indicators , *DISEASE incidence , *ANAL tumors , *SEX customs , *SEXUAL orientation identity , *RESEARCH funding , *MEN who have sex with men , *HIV , *SQUAMOUS cell carcinoma , *DISEASE risk factors - Abstract
Background Men who have sex with men (MSM) without HIV are known to be at elevated relative risk for Human papillomavirus (HPV)-associated anal cancer in comparison to men who have sex with women (MSW), but are poorly characterized in terms of anal cancer incidence due to absence of reporting of sexual behavior/identity at a population-level. Methods By combining age-specific statistics from multiple data sources (anal cancer incidence among all males; anal cancer incidence among MSM and MSW with HIV; population size of men with HIV by sexual orientation), we developed a mathematical model to estimate anal cancer incidence, annual number of cases, and proportion by (a) sexual orientation (MSM versus MSW), (b) HIV status, and (c) age (<30, 30–44, 45–59, and ≥60 years). Results Anal cancer incidence (per 100 000) among MSM without HIV was 1.4 (95% uncertainty interval [UI], 0.6 to 2.3), 17.6 (95% UI = 13.8–23.5), and 33.9 (95% UI = 28.3–42.3), at ages 30–44, 45–59 and ≥60 years, respectively. 19.1% of all male anal cancer occurred in MSM without HIV, increasing from 4% of anal cancer diagnosed at 30–44 years to 24% at ≥60 years; 54.3% occurred in MSW without HIV (increasing from 13% at age 30–44 to 67% at >60 years), and the remaining 26.6% in men (MSM and MSW combined) with HIV (decreasing from 83% at age 30–44 to 9% at >60 years). Conclusions These findings should inform anal cancer prevention recommendations in male risk groups, including, for the first time, for the important group of MSM without HIV. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
15. Incidence and Prevalence of Hepatitis C Virus Among HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP): A Systematic Review and Meta-analysis.
- Author
-
Traeger, Michael W, Harney, Brendan L, Sacks-Davis, Rachel, Santen, Daniela K van, Cornelisse, Vincent J, Wright, Edwina J, Hellard, Margaret E, Doyle, Joseph S, and Stoové, Mark A
- Subjects
- *
BISEXUAL men , *HEPATITIS C virus , *GAY men , *PRE-exposure prophylaxis , *HIV seroconversion , *SEXUALLY transmitted diseases - Abstract
Background Gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) are at increased risk for sexually transmissible infections. Hepatitis C virus (HCV) risk among PrEP users is less clear. We explored HCV prevalence and incidence among cohorts of gay and bisexual men using PrEP and sources of heterogeneity across studies. Methods This was a systematic review and meta-analysis of open-label PrEP studies to April 2022 reporting HCV prevalence at baseline or incidence during follow-up among gay and bisexual men using PrEP. Pooled prevalence and incidence estimates were calculated using random-effects meta-analysis, and subgroup analyses were performed by study- and country-level characteristics, including availability of HCV direct-acting antiviral (DAA) therapy at time of study. Results Twenty-four studies from 9 countries were included, with a total sample of 24 733 gay and bisexual men. Pooled HCV antibody baseline prevalence was 0.97% (95% CI, 0.63%–1.31%), and pooled HCV RNA baseline prevalence was 0.38% (95% CI, 0.19%–0.56%). Among 19 studies reporting HCV incidence, incidence ranged from 0.0 to 2.93/100 person-years (py); the pooled estimate was 0.83/100py (95% CI, 0.55–1.11). HCV incidence was higher in 12 studies that began follow-up before broad DAA availability (1.27/100py) than in 8 studies that began follow-up after broad DAA availability (0.34/100py) and higher in studies in Europe compared with North America and Australia. Conclusions Early reports of high HCV incidence among PrEP-using cohorts likely reflect enrollment of individuals based on specific risk-based eligibility criteria for smaller studies and enrollment before DAA scale-up. In contexts where both DAAs and PrEP have been implemented at scale, studies report lower HCV incidence. PrEP-specific HCV testing guidelines should be guided by local epidemiology. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
16. 'She showed me a new path, a way forward': exploring how navigation influences mental health among Guatemalan gay and bisexual men living with HIV.
- Author
-
Davis, Dirk A, Muessig, Kathryn E, Matthews, Derrick D, Angeles, Gustavo, McNaughton-Reyes, Luz, Guzmán, Karla, Northbrook, Sanny, and Barrington, Clare
- Subjects
- *
HIV infection epidemiology , *HIV infections , *HIV-positive persons , *SOCIAL support , *HEALTH services accessibility , *PSYCHOLOGY of LGBTQ+ people , *MOTIVATION (Psychology) , *MENTAL health , *PATIENT-centered care , *INTERVIEWING , *HOPE , *DESCRIPTIVE statistics , *MEN who have sex with men , *THEMATIC analysis , *HEALTH promotion - Abstract
Mental health problems, including anxiety and depression, are a common comorbidity among gay, bisexual and other men who have sex with men (GBMSM) living with HIV. Informed by social support theory, health navigation is a strengths-based intervention that has been demonstrated to improve HIV care outcomes. The purpose of this study was to explore how health navigation influences the mental health of GBMSM living with HIV. We analyzed longitudinal qualitative in-depth interviews conducted with GBMSM (n = 29) in a 12-month multi-component intervention to improve HIV care outcomes, including health navigation. We used narrative and thematic analytic approaches to identify salient themes, including if and how themes changed over time. Participants described that navigator support helped them maintain good mental health, prevent crises and respond to crises. Navigator support included providing motivational messaging, facilitating participants' control over their health and improving access to care, which aided with supporting mental health. Navigators also responded to acute crises by providing guidance for those newly diagnosed with HIV and support for those experiencing critical life events. Participants emphasized the importance of feeling heard and valued by their navigators and gaining hope for the future as key to their wellbeing. In conclusion, health navigation may be an effective intervention for promoting mental health among GBMSM living with HIV. Additional research is needed to examine mediating pathways between navigation and mental health, including informational support, or if navigator support moderates the relationship between stressors and mental health outcomes for GBMSM. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. Evaluation of a Statewide Online, At-Home Sexually Transmitted Infection and Human Immunodeficiency Virus Screening Program.
- Author
-
Higgins, David M, Moore, MaShawn, Alderton, Lucy, Weinberg, Laura, Hickok, Andrew M, Yale, Andrew, and Wendel, Karen A
- Subjects
- *
SEXUALLY transmitted disease diagnosis , *GONORRHEA diagnosis , *DIAGNOSIS of HIV infections , *CHLAMYDIA infection diagnosis , *HOME diagnostic tests , *SEXUAL orientation , *EVALUATION of human services programs , *INTERNET , *HISPANIC Americans , *MEDICAL screening , *MEDICAL care , *DESCRIPTIVE statistics , *RESEARCH funding , *MEN who have sex with men , *WORLD Wide Web - Abstract
Background Innovative approaches such as online, at-home programs may address important barriers to sexually transmitted infection (STI) and human immunodeficiency virus (HIV) screening in the United States. This study evaluated the first year of an online, at-home program offering HIV and triple-site (urogenital, rectal, and pharyngeal) gonorrhea (GC) and chlamydia (CT) testing in Colorado. Methods Test Yourself Colorado (TYC) is an online, at-home program that provides free mailed HIV tests and/or GC/CT tests to Colorado adults. Program use and outcomes between 1 June 2021 and 31 May 2022 were analyzed. Results A total of 1790 unique clients utilized TYC. Of 1709 clients who ordered HIV tests, 508 (29.7%) were men who have sex with men (MSM), and 41.3% (210/508) of these clients reported having never been tested for HIV before or were not tested in the prior year. Hispanic clients had lower STI test return rates (37.1%; 134/361) compared with non-Hispanic clients (45.9%; 518/1128) (P =.003). Positive STI tests were identified in 9.6% (68/708) of clients. Positive STI tests were more common in MSM clients (15.7%; 34/216) compared with all other sexual orientations (6.9%; 34/492) (P <.001). STI treatment was confirmed in 80.9% (55/68) of clients. Conclusions The TYC online, home testing portal is a scalable tool that reaches clients at risk of STIs and HIV and navigates those with positive STI tests to treatment. HIV/STI home testing programs need to further assess and address utilization and outcomes for disparities by race and ethnicity to assure programs equitably benefit all at-risk communities. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
18. Impact of Human Immunodeficiency Virus and Recreational Drugs on Cognitive Functions.
- Author
-
Henrard, Sophie, Trotta, Nicola, Rovai, Antonin, Coolen, Tim, Slama, Hichem, Bertels, Julie, Puttaert, Delphine, Goffard, Jean-Christophe, Vooren, Jean-Paul Van, Goldman, Serge, and Tiège, Xavier De
- Subjects
- *
LIFESTYLES , *BRAIN , *EXECUTIVE function , *DRUG abuse , *COGNITION , *MAGNETIC resonance imaging , *POSITRON emission tomography , *RADIOPHARMACEUTICALS , *MEN who have sex with men , *DEOXY sugars , *HIV , *NEURORADIOLOGY - Abstract
Background This prospective study characterizes the structural and metabolic cerebral correlates of cognitive impairments found in a preclinical setting that considers the lifestyle of young European men exposed to human immunodeficiency virus (HIV), including recreational drugs. Methods Simultaneous structural brain magnetic resonance imaging (MRI) and positron emission tomography using [18F]-fluorodeoxyglucose (FDG-PET) were acquired on a hybrid PET-MRI system in 23 asymptomatic young men having sex with men with HIV (HIVMSM; mean age, 33.6 years [range, 23–60 years]; normal CD4+ cell count, undetectable viral load). Neuroimaging data were compared with that of 26 young seronegative men under HIV preexposure prophylaxis (PrEPMSM), highly well matched for age and lifestyle, and to 23 matched young seronegative men (controls). A comprehensive neuropsychological assessment was also administered to the HIVMSM and PrEPMSM participants. Results HIVMSM had lower performances in executive, attentional, and working memory functions compared to PrEPMSM. No structural or metabolic differences were found between those 2 groups. Compared to controls, HIVMSM and PrEPMSM exhibited a common hypometabolism in the prefrontal cortex that correlated with the level of recreational drug use. No structural brain abnormality was found. Conclusions Abnormalities of brain metabolism in our population of young HIVMSM mainly relate to recreational drug use rather than HIV per se. A complex interplay between recreational drugs and HIV might nevertheless be involved in the cognitive impairments observed in this population. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
19. Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies.
- Author
-
Wei, Feixue, Goodman, Marc T, Xia, Ningshao, Zhang, Jun, Giuliano, Anna R, D'Souza, Gypsyamber, Hessol, Nancy A, Loeff, Maarten F Schim van der, Dai, Jianghong, Neukam, Karin, Pokomandy, Alexandra de, Poynten, I Mary, Geskus, Ronald B, Burgos, Joaquin, Etienney, Isabelle, Moscicki, Anna-Barbara, Donà, Maria Gabriella, Gillison, Maura L, Nyitray, Alan G, and Nowak, Rebecca G
- Subjects
- *
HIV infections , *IMMUNIZATION , *HUMAN sexuality , *AGE distribution , *HEALTH status indicators , *DISEASE incidence , *EARLY detection of cancer , *SEX distribution , *ANAL tumors , *RISK assessment , *PAPILLOMAVIRUS diseases , *DISEASE prevalence , *HUMAN papillomavirus vaccines , *ANAL diseases , *SEXUAL partners , *MEN who have sex with men , *HIV , *SECONDARY analysis , *DISEASE risk factors , *DISEASE complications - Abstract
Background Understanding the natural history of anal high-risk human papillomavirus (hrHPV) infection is key for designing anal cancer prevention programs but has not been systematically characterized. Methods We reanalyzed data from 34 studies including 16 164 individuals in 6 risk groups defined by human immunodeficiency virus (HIV) status, sex, and male sexuality: men who have sex with men (MSM) and people with HIV (MSMWH), HIV-negative MSM, women with HIV (WWH), HIV-negative women, men who have sex with women (MSW) with HIV (MSWWH), and HIV-negative MSW. We used Markov models to estimate incidence and clearance of 13 hrHPV types and their determinants. Results Human papillomavirus (HPV) 16 had the highest incidence-clearance ratio of the hrHPV types. MSMWH had the highest hrHPV incidence (eg, 15.5% newly HPV-16 infected within 2 years), followed by HIV-negative MSM (7.5%), WWH (6.6%), HIV-negative women (2.9%), MSWWH (1.7%), and HIV-negative MSW (0.7%). Determinants of HPV-16 incidence included HIV status and number of sexual partners for MSM, women, and MSW, and anal sex behavior for MSM only. HPV-16 clearance was lower for people with HIV (PWH) and lower for prevalent than incident infection. Among MSM, increasing age was associated with lower clearance of prevalent, but not incident, HPV-16 infection. Conclusions This robust and unifying analysis of anal hrHPV natural history is essential to designing and predicting the impact of HPV vaccination and HPV-based screening programs on anal cancer prevention, particularly in MSM and PWH. Importantly, it demonstrates the higher carcinogenic potential of longstanding anal prevalent hrHPV infection than more recent incident infection. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. Efficacy of a Carrageenan Gel in Increasing Clearance of Anal Human Papillomavirus Infections in Men: Interim Analysis of a Double-Blind, Randomized Controlled Trial.
- Author
-
Laurie, Cassandra, El-Zein, Mariam, Tota, Joseph, Khosrow-Khavar, Farzin, Tellier, Pierre-Paul, Coutlée, François, Pokomandy, Alexandra de, Franco, Eduardo L, and Group, Lubricant Investigation in Men to Inhibit Transmission of Human Papillomavirus Infection (LIMIT-HPV) Study
- Subjects
- *
HUMAN papillomavirus , *PAPILLOMAVIRUS diseases , *CARRAGEENANS , *CLINICAL trial registries , *HIV - Abstract
Preclinical studies have demonstrated carrageenan's anti–human papillomavirus (HPV) activity. We assessed efficacy of a carrageenan-based gel compared to a placebo gel in increasing the clearance of anal HPV infections among gay, bisexual, and other men who have sex with men (gbMSM). Of 255 enrolled gbMSM, 134 were HPV positive at baseline and had valid HPV results for ≥2 visits. Carrageenan did not differ from placebo in clearing all baseline infections (hazard ratio, 0.84 [95% confidence interval,.31–2.27]), based on having 2 consecutive HPV-negative visits following at least 1 HPV-positive visit. There were no remarkable differences for analyses at the HPV type level or by human immunodeficiency virus status. Clinical Trials Registration NCT02354144. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
21. Reply to Niu and Drain.
- Author
-
Anderson, Peter L, Marzinke, Mark A, and Glidden, David V
- Subjects
- *
HIV prevention , *AIDS education , *HIV , *SEX distribution , *EMTRICITABINE-tenofovir , *PRE-exposure prophylaxis , *MEN who have sex with men , *CISGENDER people , *TRANS women - Published
- 2024
- Full Text
- View/download PDF
22. Mycoplasma genitalium and Antimicrobial Resistance Among a Cohort of West African Men Who Have Sex With Men Using Preexposure Prophylaxis (CohMSM-PrEP ANRS 12369-Expertise France Study).
- Author
-
Baetselier, Irith De, Vuylsteke, Bea, Cuylaerts, Vicky, Cuer, Benjamin, Yaya, Issifou, Mensah, Ephrem, Dah, Elias, Anoma, Camille, Koné, Amadou, Diandé, Souba, Dagnra, Anoumou, Fayé-Ketté, Hortense, Yeo, Alain, Smet, Hilde, Bossche, Dorien Van den, Keita, Bintou Dembélé, Spire, Bruno, Laurent, Christian, Crucitti, Tania, and Group, CohMSM-PrEP Study
- Subjects
- *
DRUG resistance in microorganisms , *AFRICANS , *MYCOPLASMA , *HIV , *RIBOSOMAL RNA - Abstract
Background Antimicrobial resistance to macrolides and fluoroquinolones in Mycoplasma genitalium (MG) among men who have sex with men (MSM) is worryingly high in high-resource countries. Data in Africa are lacking. We aimed to assess the burden of MG including the presence of resistance-associated mutations (RAMs) in MG among MSM using human immunodeficiency virus preexposure prophylaxis in Burkina Faso, Côte d'Ivoire, Mali, and Togo. Methods MSM were included in a prospective cohort study (2017–2021). Molecular detection of MG in urine, anorectal, and pharyngeal samples was performed at baseline and after 6 and 12 months. Detection of RAMs to macrolides and fluoroquinolones was performed by sequencing the 23S ribosomal RNA, parC , and gyrA genes. A sample was found to be possibly resistant to fluoroquinolones if alterations were found in ParC position 83/87. Results Of 598 participants, 173 (28.9%) were positive at least once for MG and global point-prevalence was 19.4%. Interestingly, 238 of 250 (95.2%) infections were asymptomatic and 72 of 138 MG infections with follow-up data (52.2%) cleared during the study. Only 1 macrolide RAM was found (0.6%). Prevalence of fluoroquinolones RAMs was 11.3% overall, ranging from 2.4% in Burkina Faso to 17.5% in Mali. Conclusions Although MG was highly prevalent in these MSM, macrolide resistance was almost nonexistent. Nevertheless, >10% of the samples were possibly resistant to fluoroquinolones. Heterogeneity in the prevalence of fluoroquinolone RAMs between countries may be explained by different antimicrobial consumption in humans and animals. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
23. Projected Effects of Disruptions to Human Immunodeficiency Virus (HIV) Prevention Services During the Coronavirus Disease 2019 Pandemic Among Black/African American Men Who Have Sex With Men in an Ending the HIV Epidemic Priority Jurisdiction.
- Author
-
Labs, Jennifer, Nunn, Amy S, Chan, Philip A, Bessey, S, Park, Carolyn J, Marshall, Brandon D L, Patel, Rupa R, Mena, Leandro A, and Goedel, William C
- Subjects
- *
COVID-19 pandemic , *AFRICAN American men , *HIV , *COVID-19 , *HIV seroconversion , *HIV infection transmission , *CORONAVIRUS diseases - Abstract
Background Disruptions in access to in-person human immunodeficiency virus (HIV) preventive care during the coronavirus disease 2019 (COVID-19) pandemic may have a negative impact on our progress towards the Ending the HIV Epidemic goals in the United States. Methods We used an agent-based model to simulate HIV transmission among Black/African American men who have sex with men in Mississippi over 5 years to estimate how different reductions in access affected the number of undiagnosed HIV cases, new pre-exposure prophylaxis (PrEP) starts, and HIV incidence. Results We found that each additional 25% decrease in HIV testing and PrEP initiation was associated with decrease of 20% in the number of cases diagnosed and 23% in the number of new PrEP starts, leading to a 15% increase in HIV incidence from 2020 to 2022. Conclusions Unmet need for HIV testing and PrEP prescriptions during the COVID-19 pandemic may temporarily increase HIV incidence in the years immediately after the disruption period. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
24. Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009–2019.
- Author
-
Harney, Brendan L, Sacks-Davis, Rachel, Santen, Daniela K van, Traeger, Michael, Wilkinson, Anna L, Asselin, Jason, El-Hayek, Carol, Fairley, Christopher K, Roth, Norman, Bloch, Mark, Matthews, Gail, Donovan, Basil, Guy, Rebecca, Stoové, Mark, Hellard, Margaret E, Doyle, Joseph S, and (ACCESS), Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood-borne Viruses
- Subjects
- *
HIV prevention , *HEPATITIS C diagnosis , *HIV-positive persons , *CONFIDENCE intervals , *HEPATITIS C , *DESCRIPTIVE statistics , *MEN who have sex with men , *GAY men , *POISSON distribution - Abstract
Background Hepatitis C virus (HCV) infection has been reported among gay, bisexual, and other men who have sex with men (GBM) globally including GBM with human immunodeficiency virus (HIV) and HIV-negative GBM, particularly those using HIV preexposure prophylaxis (PrEP). In Australia, HCV direct-acting antiviral treatment (DAA) was government-funded from 2016. Large implementation studies of PrEP also began in 2016. We examined HCV incidence among GBM to assess whether HCV incidence has changed since 2015. Methods Data were drawn from the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance. We included GBM who tested HCV antibody negative at their first test and had ≥1 subsequent test. Generalized linear modeling (Poisson distribution) was used to examine HCV incidence from 2009 to 2019 stratified by HIV status, and among HIV-negative GBM prescribed PrEP from 2016 to 2019. Results Among 6744 GBM with HIV, HCV incidence was 1.03 per 100 person-years (PY). Incidence declined by 78% in 2019 compared to 2015 (incidence rate ratio [IRR], 0.22 [95% confidence interval {CI}:.09–.55]). Among 20 590 HIV-negative GBM, HCV incidence was 0.20/100 PY, with no significant change over time. Among 11 661 HIV-negative GBM prescribed PrEP, HCV incidence was 0.29/100 PY. Compared to 2016, incidence among GBM prescribed PrEP declined by 80% in 2019 (IRR, 0.20 [95% CI:.06–.64]). Conclusions HCV incidence among GBM living with HIV declined following DAA availability. There was no observed change in HCV incidence among HIV-negative GBM overall. Among GBM prescribed PrEP, incidence declined since the early years of PrEP implementation in Australia. Australia is on track to eliminate HCV among GBM before global 2030 targets. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
25. Oral and Anal Carriage of Streptococcus pneumoniae Among Sexually Active Men With HIV Who Have Sex With Men.
- Author
-
Tinggaard, Michaela, Slotved, Hans-Christian, Fuursted, Kurt, Storgaard, Merete, Dröse, Sandra, Johansen, Isik Somuncu, Thorsteinsson, Kristina, Kronborg, Gitte, Lebech, Anne-Mette, Benfield, Thomas, and Somuncu Johansen, Isik
- Subjects
- *
MEN who have sex with men , *STREPTOCOCCUS pneumoniae , *HIV , *HIV infection epidemiology , *HIV infection complications , *ANUS , *HUMAN sexuality , *HOMOSEXUALITY , *STREPTOCOCCUS , *RESEARCH funding - Abstract
People with HIV are at increased risk of pneumococcal disease. We investigate oral and anal carriage rates of Streptococcus pneumoniae by molecular methods among 82 men with HIV who have sex with men (MSM). A questionnaire, oral wash, and anal swab samples were obtained at baseline and 12 months. Oral carriage rates were 32.9% (27/82) at baseline and 41.7% (30/72) at follow-up. Anal carriage rates were 2.4% (2/82) at baseline and 2.9% (2/70) at follow-up. Genogroup 24 was predominant. Results suggest high oral carriage rates of S. pneumoniae among MSM living with HIV. A minority were anal carriers. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
26. Sexuality-based stigma and access to care: intersecting perspectives between healthcare providers and men who have sex with men in HIV care centres in Senegal.
- Author
-
Ndione, Albert Gautier, Procureur, Fanny, Senne, Jean-Noël, Cornaglia, Francesca, Gueye, Khady, Ndour, Cheikh Tidiane, and Lépine, Aurélia
- Subjects
MEDICAL personnel ,MEDICAL disclosure ,SOCIAL stigma ,HIV ,PRE-exposure prophylaxis ,MEN who have sex with men ,HIV infections ,HEALTH services accessibility ,HOMOSEXUALITY ,RESEARCH funding - Abstract
Men who have sex with men (MSM) in Senegal face a challenging socio-legal context, marked by homophobia and the illegality of homosexuality. In addition, human immunodeficiency virus (HIV) prevalence among MSM is 27.6%, 46 times greater than the one in the general population (0.5%). Nevertheless, access to healthcare by MSM may be hampered by stigmatizing attitudes from health facility staff (medical and non-medical). This article describes the health facility staff/MSM relationship and analyses its effects on access to healthcare by MSM. The data used were collected through a field survey based on observations and qualitative interviews conducted in 2019 and 2020 with 16 MSM, 1 non-governmental organization (NGO) staff and 9 healthcare providers in Dakar (the capital city) and Mbour (secondary city on the West Coast) hospitals. The data were subject to a thematic analysis assisted by the ATLAS software. The relationship between MSM and healthcare providers is ambiguous. On the one hand, healthcare providers are torn between their professional duty to treat MSM and the cost of being stigmatized by other colleagues. Therefore, they often limit their empathy with MSM within the hospital context. On the other hand, MSM, trusting in the confidentiality of healthcare providers, feel safe in the care pathway. However, we identify the following stigmatizing factors limiting access to care include (1) fear of meeting a relative, (2) difficult relationships with non-medical support staff (mainly security guards), (3) HIV status disclosure and (4) potential conflicts with other MSM. This study is unique as it includes non-medical staff in its respondents. It shows that hospitals are divided into several areas, based on the stigma perceived by MSM. It is important to map out MSM's care trajectories and spaces and to identify all types of staff working within them, including non-medical staff, and enrol them in stigma reduction interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
27. Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group.
- Author
-
Nguyen, Huyen, Hampel, Benjamin, Nuñez, David Garcia, Battegay, Manuel, Hachfeld, Anna, Bernasconi, Enos, Calmy, Alexandra, Cavassini, Matthias, Vernazza, Pietro, Fellay, Jacques, Rudolph, Hannes, Huber, Michael, Leuzinger, Karoline, Perreau, Matthieu, Scherrer, Alexandra, Ramette, Alban Nicolas, Yerly, Sabine, Günthard, Huldrych F, Kouyos, Roger D, and Kusejko, Katharina
- Subjects
- *
HIV infection epidemiology , *HIV infection transmission , *HIV infection risk factors , *RISK-taking behavior , *TRANS women , *MENTAL health , *RISK assessment , *SOCIOECONOMIC factors , *INFECTIOUS disease transmission , *DESCRIPTIVE statistics , *MEN who have sex with men , *LONGITUDINAL method - Abstract
Background As trans women are disproportionately affected by the HIV epidemic, and are still understudied, we aimed to identify and characterize the trans women in the Swiss HIV Cohort Study (SHCS). Methods A combination of criteria from pre-existing cohort data was used to identify trans women. Information on socioeconomic factors, clinical data, risk behaviors, and mental health was collected. We also described their phylogenetic patterns within HIV transmission networks in relation to other risk groups. Results We identified 89 trans women of a total 20 925 cohort participants. Trans women were much more likely to be Asian (30.3%) and Hispanic (15.7%) than men who have sex with men (MSM) (2.5% and 4.1%; P < .001) and cis heterosexual (HET) women (7.0% and 3.3%; P < .001). Trans women were more similar to cis HET women in some measures like educational level (postsecondary education attainment: 22.6% and 20.7% [ P = .574] vs 46.5% for MSM [ P < .001]), while being more similar to MSM for measures like prior syphilis diagnosis (36.0% and 44.0% [ P = .170] vs 6.7% for cis HET women [ P < .001]). 11.2% of trans women have been previously hospitalized for psychological reasons compared with 4.2% of MSM (P = .004) and 5.1% of cis HET women (P = .025). Analysis of transmission clusters containing trans women suggested greater affinity within the transmission networks to MSM compared with cis HET women. Conclusions Trans women are epidemiologically distinct in the setting of the Swiss HIV epidemic, warranting better identification and study to better serve this underserved risk group. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
28. Impact of Racial Categorization on Effect Estimates: An HIV Stigma Analysis.
- Author
-
Facente, Shelley N, Lam-Hine, Tracy, Bhatta, Dharma N, and Hecht, Jennifer
- Subjects
- *
HIV infection epidemiology , *HIV infections , *HIV-positive persons , *ATTITUDE (Psychology) , *MULTIPLE regression analysis , *RACE , *GROUP identity , *SOCIAL stigma , *CULTURAL pluralism , *RISK assessment , *PSYCHOSOCIAL factors , *MEN who have sex with men , *ETHNIC groups , *STATISTICAL models , *AFRICAN Americans - Abstract
Suboptimal racial categorization potentially introduces bias in epidemiologic analysis and interpretation, making it difficult to appropriately measure factors leading to racial health disparities. As part of an analysis focused on predictors of experiencing human immunodeficiency status (HIV)-related stigma among men who have sex with men living with HIV in San Francisco, we struggled with the most appropriate ways to categorize people who reported more than 1 racial identity, and we aimed to explore the implications of different methodological choices in this analysis. We fitted 3 different multivariable linear regression models, each utilizing a different approach to racial categorization: the "multiracial," "othering," and "hypodescent" models. We estimated an adjusted risk difference in mean score for reported frequency of experiencing HIV-related stigma on a 4-point scale, adjusting for age, race, gender identity, injection history, housing, mental health concerns, and viral load. Use of a hypodescent model for racial categorization led to a shift in the point estimate through the null for Blacks/African Americans, and it improved precision for that group. However, it obscured the association of increased stigma and race for multiracial people, compared with monoracial counterparts. We conclude that methodological decisions related to racial categorization of participants can dramatically affect race-related study findings in predictor regression models. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
29. Intersection of Syphilis and Human Immunodeficiency Virus (HIV) Networks to Identify Opportunities to Enhance HIV Prevention.
- Author
-
Dennis, Ann M, Cressman, Andrew, Pasquale, Dana, Frost, Simon D W, Kelly, Elizabeth, Guy, Jalila, Mobley, Victoria, Samoff, Erika, Hurt, Christopher B, Mcneil, Candice, Hightow-Weidman, Lisa, Carry, Monique, Hogben, Matthew, and Seña, Arlene C
- Subjects
- *
HIV prevention , *PUBLIC health surveillance , *SYPHILIS , *VIRAL load , *DESCRIPTIVE statistics , *SEXUAL minorities , *CONTACT tracing , *MOLECULAR epidemiology , *MEN who have sex with men , *HIV - Abstract
Background Human immunodeficiency virus (HIV) and syphilis infection continue at disproportionate rates among minority men who have sex with men (MSM) in the United States. The integration of HIV genetic clustering with partner services can provide important insight into local epidemic trends to guide interventions and control efforts. Methods We evaluated contact networks of index persons defined as minority men and transgender women diagnosed with early syphilis and/or HIV infection between 2018 and 2020 in 2 North Carolina regions. HIV clusters were constructed from pol sequences collected through statewide surveillance. A combined "HIV-risk" network, which included persons with any links (genetic or sexual contact) to HIV-positive persons, was evaluated by component size, demographic factors, and HIV viral suppression. Results In total, 1289 index persons were identified and 55% named 1153 contacts. Most index persons were Black (88%) and young (median age 30 years); 70% had early syphilis and 43% had prevalent HIV infection. Most people with HIV (65%) appeared in an HIV cluster. The combined HIV-risk network (1590 contact network and 1500 cluster members) included 287 distinct components; however, 1586 (51%) were in a single component. Fifty-five percent of network members with HIV had no evidence of viral suppression. Overall, fewer index persons needed to be interviewed to identify 1 HIV-positive member without viral suppression (1.3 vs 4.0 for contact tracing). Conclusions Integration of HIV clusters and viral loads illuminate networks with high HIV prevalence, indicating recent and ongoing transmission. Interventions intensified toward these networks may efficiently reach persons for HIV prevention and care re-engagement. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
30. Transitions Between Preexposure Prophylaxis Eligibility States and HIV Infection in the Lisbon Cohort of HIV-Negative Men Who Have Sex With Men: A Multistate Model Analysis.
- Author
-
Meireles, Paula, Moreira, Carla, Rocha, Miguel, Plankey, Michael, and Barros, Henrique
- Subjects
- *
HIV infection epidemiology , *HIV prevention , *HIV seronegativity , *HIV-positive persons , *CONFIDENCE intervals , *TIME , *ANTIRETROVIRAL agents , *ELIGIBILITY (Social aspects) , *DESCRIPTIVE statistics , *PREVENTIVE medicine , *MEN who have sex with men , *STATISTICAL models , *LONGITUDINAL method - Abstract
We aimed to describe transitions between preexposure prophylaxis (PrEP) eligibility and human immunodeficiency virus (HIV) infection among HIV-negative men who have sex with men (MSM). We used data from 1,885 MSM, who had not used PrEP, enrolled in the Lisbon Cohort of MSM, with at least 2 consecutive measurements of PrEP eligibility from 2014–2020. A time-homogeneous Markov multistate model was applied to describe the transitions between states of PrEP eligibility—eligible and ineligible—and from these to HIV infection (HIV). The intensities of the transitions were closer for ineligible-to-eligible and eligible-to-ineligible transitions (intensity ratio, 1.107, 95% confidence interval (CI): 1.080, 1.176), while the intensity of the eligible-to-HIV transition was higher than that for ineligible-to–HIV transition (intensity ratio, 9.558, 95% CI: 0.738, 65.048). The probabilities of transitions increased with time; for 90 days, the probabilities were similar for the ineligible-to-eligible and eligible-to-ineligible transitions (0.285 (95% CI: 0.252, 0.319) vs. 0.258 (95% CI: 0.228, 0.287)), while the eligible-to-HIV transition was more likely than ineligible-to-HIV (0.004 (95% CI: 0.003, 0.007) vs. 0.001 (95% CI: 0.001, 0.008)) but tended to become closer with time. Being classified as ineligible was a short-term indicator of a lower probability of acquiring HIV. Once an individual moved to eligible, he was at a higher risk of seroconversion, demanding a timely delivery of PrEP. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
31. Increasing Frequency and Transmission of HIV-1 Non-B Subtypes Among Men Who Have Sex With Men in the Swiss HIV Cohort Study.
- Author
-
Ramirez, Jessy J Duran, Ballouz, Tala, Nguyen, Huyen, Kusejko, Katharina, Chaudron, Sandra E, Huber, Michael, Hirsch, Hans H, Perreau, Matthieu, Ramette, Alban, Yerly, Sabine, Cavassini, Matthias, Stöckle, Marcel, Furrer, Hansjakob, Vernazza, Pietro, Bernasconi, Enos, Günthard, Huldrych F, Kouyos, Roger D, Study, Swiss HIV Cohort, Duran Ramirez, Jessy J, and Swiss HIV Cohort Study
- Subjects
- *
PUBLIC health surveillance , *HIV , *MEN who have sex with men , *COHORT analysis , *MOLECULAR clusters - Abstract
Background: In Switzerland, HIV-1 transmission among men who have sex with men (MSM) has been dominated by subtype B, whilst non-B subtypes are commonly attributed to infections acquired abroad among heterosexuals. Here, we evaluated the temporal trends of non-B subtypes and the characteristics of molecular transmission clusters (MTCs) among MSM.Methods: Sociodemographic and clinical data and partial pol sequences were obtained from participants enrolled in the Swiss HIV Cohort Study. For non-B subtypes, maximum likelihood trees were constructed, from which Swiss MTCs were identified and analyzed by transmission group.Results: Non-B subtypes were identified in 8.1% (416/5116) of MSM participants. CRF01_AE was the most prevalent strain (3.5%), followed by subtype A (1.2%), F (1.1%), CRF02_AG (1.1%), C (0.9%), and G (0.3%). Between 1990 and 2019, an increase in the proportion of newly diagnosed individuals (0/123 [0%] to 11/32 [34%]) with non-B subtypes in MSM was found. Across all non-B subtypes, the majority of MSM MTCs were European. Larger MTCs were observed for MSM than heterosexuals.Conclusions: We found a substantial increase in HIV-1 non-B subtypes among MSM in Switzerland and the occurrence of large MTCs, highlighting the importance of molecular surveillance in guiding public health strategies targeting the HIV-1 epidemic. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
32. Molecular epidemiology of HIV-1 in Oryol Oblast, Russia.
- Author
-
Safina, Ksenia R, Sidorina, Yulia, Efendieva, Natalya, Belonosova, Elena, Saleeva, Darya, Kirichenko, Alina, Kireev, Dmitry, Pokrovsky, Vadim, and Bazykin, Georgii A
- Subjects
MOLECULAR epidemiology ,HIV ,MEN who have sex with men ,BLACK men ,AFRICAN American men - Abstract
The HIV/AIDS epidemic in Russia is growing, with approximately 100,000 people infected annually. Molecular epidemiology can provide insight into the structure and dynamics of the epidemic. However, its applicability in Russia is limited by the weakness of genetic surveillance, as viral genetic data are only available for <1 per cent of cases. Here, we provide a detailed description of the HIV-1 epidemic for one geographic region of Russia, Oryol Oblast, by collecting and sequencing viral samples from about a third of its known HIV-positive population (768 out of 2,157 patients). We identify multiple introductions of HIV-1 into Oryol Oblast, resulting in eighty-two transmission lineages that together comprise 66 per cent of the samples. Most introductions are of subtype A (315/332), the predominant HIV-1 subtype in Russia, followed by CRF63 and subtype B. Bayesian analysis estimates the effective reproduction number R
e for subtype A at 2.8 [1.7–4.4], in line with a growing epidemic. The frequency of CRF63 has been growing more rapidly, with the median Re of 11.8 [4.6–28.7], in agreement with recent reports of this variant rising in frequency in some regions of Russia. In contrast to the patterns described previously in European and North American countries, we see no overrepresentation of males in transmission lineages; meanwhile, injecting drug users are overrepresented in transmission lineages. This likely reflects the structure of the HIV-1 epidemic in Russia dominated by heterosexual and, to a smaller extent, people who inject drugs transmission. Samples attributed to men who have sex with men (MSM) transmission are associated with subtype B and are less prevalent than expected from the male-to-female ratio for this subtype, suggesting underreporting of the MSM transmission route. Together, our results provide a high-resolution description of the HIV-1 epidemic in Oryol Oblast, Russia, characterized by frequent interregional transmission, rapid growth of the epidemic, and rapid displacement of subtype A with the recombinant CRF63 variant. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
33. Quantifying rates of HIV-1 flow between risk groups and geographic locations in Kenya: A country-wide phylogenetic study.
- Author
-
Nduva, George M, Otieno, Frederick, Kimani, Joshua, Wahome, Elizabeth, McKinnon, Lyle R, Cholette, Francois, Majiwa, Maxwell, Masika, Moses, Mutua, Gaudensia, Anzala, Omu, Graham, Susan M, Gelmon, Larry, Price, Matt A, Smith, Adrian D, Bailey, Robert C, Baele, Guy, Lemey, Philippe, Hassan, Amin S, Sanders, Eduard J, and Esbjörnsson, Joakim
- Subjects
HIV ,PHYSIOGRAPHIC provinces ,MEN who have sex with men ,INFECTIOUS disease transmission - Abstract
In Kenya, HIV-1 key populations including men having sex with men (MSM), people who inject drugs (PWID) and female sex workers (FSW) are thought to significantly contribute to HIV-1 transmission in the wider, mostly heterosexual (HET) HIV-1 transmission network. However, clear data on HIV-1 transmission dynamics within and between these groups are limited. We aimed to empirically quantify rates of HIV-1 flow between key populations and the HET population, as well as between different geographic regions to determine HIV-1 'hotspots' and their contribution to HIV-1 transmission in Kenya. We used maximum-likelihood phylogenetic and Bayesian inference to analyse 4058 HIV-1 pol sequences (representing 0.3 per cent of the epidemic in Kenya) sampled 1986–2019 from individuals of different risk groups and regions in Kenya. We found 89 per cent within-risk group transmission and 11 per cent mixing between risk groups, cyclic HIV-1 exchange between adjoining geographic provinces and strong evidence of HIV-1 dissemination from (i) West-to-East (i.e. higher-to-lower HIV-1 prevalence regions), and (ii) heterosexual-to-key populations. Low HIV-1 prevalence regions and key populations are sinks rather than major sources of HIV-1 transmission in Kenya. Targeting key populations in Kenya needs to occur concurrently with strengthening interventions in the general epidemic. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
34. emergence and transmission dynamics of HIV-1 CRF07_BC in Mainland China.
- Author
-
Li, Xingguang, Li, Yanping, Liu, Haizhou, Trovão, Nídia S, and Foley, Brian T
- Subjects
AIDS ,BLACK men ,HUMAN migrations ,INFECTIOUS disease transmission ,HIV ,MEN who have sex with men ,PROTEIN structure - Abstract
A total of 1155 partial pol gene sequences of human immunodeficiency virus (HIV)-1 CRF07_BC were sampled between 1997 and 2015, spanning 13 provinces in Mainland China and risk groups [heterosexual, injecting drug users (IDU), and men who have sex with men (MSM)] to investigate the evolution, adaptation, spatiotemporal and risk group dynamics, migration patterns, and protein structure of HIV-1 CRF07_BC. Due to the unequal distribution of sequences across time, location, and risk group in the complete dataset ('full1155'), subsampling methods were used. Maximum-likelihood and Bayesian phylogenetic analysis as well as discrete trait analysis of geographical location and risk group were carried out. To study mutations of a cluster of HIV-1 CRF07_BC (CRF07-1), we performed a comparative analysis of this cluster to the other CRF07_BC sequences ('backbone_295') and mapped the mutations observed in the respective protein structure. Our findings showed that HIV-1 CRF07_BC most likely originated among IDU in Yunnan Province between October 1992 to July 1993 [95 per cent hightest posterior density (HPD): May 1989–August 1995] and that IDU in Yunnan Province and MSM in Guangdong Province likely served as the viral sources during the early and more recent spread in Mainland China. We also revealed that HIV-1 CRF07-1 has been spreading for roughly 20 years and continues to cause local transmission in Mainland China and worldwide. Overall, our study sheds light on the dynamics of HIV-1 CRF07_BC distribution patterns in Mainland China. Our research may also be useful in formulating public health policies aimed at controlling acquired immune deficiency syndrome in Mainland China and globally. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
35. Heterogeneity in the Prevalence of High-Risk Human Papillomavirus Infection in Human Immunodeficiency Virus-Negative and Human Immunodeficiency Virus-Positive Men Who Have Sex With Men in West Africa.
- Author
-
Yaya, Issifou, Boyer, Véronique, Ehlan, Phyllis Amivi, Coulibaly, Alou, Agboyibor, Mawuényégan Kouamivi, Traoré, Issa, Kouamé, Malan Jean-Baptiste, Maiga, Alassane Kader, Kotchi, Ochoh Rachelle, Nyasenu, Yawo Tufa, Maradan, Gwenaëlle, Rojas-Castro, Daniela, Diallo, Fodié, Anoma, Camille, Dah, Ter Tiero Elias, Mensah, Ephrem, Keita, Bintou Dembélé, Spire, Bruno, Dagnra, Claver Anoumou, and Laurent, Christian
- Subjects
- *
HIV infections , *CONFIDENCE intervals , *CROSS-sectional method , *MULTIVARIATE analysis , *RISK assessment , *HOMOSEXUALITY , *PAPILLOMAVIRUS diseases , *DISEASE prevalence , *HUMAN papillomavirus vaccines , *DESCRIPTIVE statistics , *MEN who have sex with men , *LOGISTIC regression analysis , *ODDS ratio , *ANAL sex , *EDUCATIONAL attainment , *UNSAFE sex , *DISEASE risk factors - Abstract
Background Men who have sex with men (MSM) are at high risk of human papillomavirus (HPV) infection. We assessed (i) the prevalence of high-risk HPV (HR-HPV) infection and associated factors, and (ii) the prevalence of vaccine-preventable HPV infections in MSM in Burkina Faso, Côte d'Ivoire, Mali, and Togo. Methods A cross-sectional study was conducted in 2017–2018 among MSM ≥18 years old followed in community-based clinics. HPV infection was investigated in oral and anal samples using the e-BRID system. Factors associated with HR-HPV infection were identified using multivariate logistic regressions. Results Among 631 participants, 425 were HIV-negative and 206 HIV-positive. HR-HPV prevalence ranged from 9.2% to 34.8% in the former, and 33.3% to 71.0% in the latter, according to the study country. In multivariate analysis, HIV infection (adjusted odds ratio (aOR) 3.61, 95% confidence interval (CI) 2.48–5.27) and study country (4.73, 2.66–8.43 for Mali; 3.12, 1.68–5.80 for Burkina Faso; 3.51, 1.92–6.42 for Togo) were associated with HR-HPV infection. Other associated factors were low educational level, self-defined homosexual identity, and condomless anal sex. The prevalence of infections which can be prevented with bivalent, quadrivalent, and nonavalent vaccines was 5.9, 27.1, and 34.6% in HIV-negative participants, and 18.9, 43.7, and 54.9% in HIV-positive participants, respectively. Conclusions HR-HPV prevalence was very heterogeneous between the study countries in both HIV-negative and HIV-positive MSM. Vaccine-preventable HPV infections predominated. Vaccination should be proposed to young MSM to reduce the burden of HPV infection in this vulnerable population and their female partners in West Africa. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
36. Independent epidemic patterns of HIV-1 CRF01_AE lineages driven by mobile population in Shenzhen, an immigrant city of China.
- Author
-
An, Minghui, Zheng, Chenli, Li, Hao, Chen, Lin, Yang, Zhengrong, Gan, Yongxia, Han, Xiaoxu, Zhao, Jin, and Shang, Hong
- Subjects
BASIC reproduction number ,MEN who have sex with men ,VIRAL transmission ,HIV ,INFECTIOUS disease transmission - Abstract
Shenzhen, a city with >12 million migrant population, may play a key role in the spread of human immunodeficiency virus (HIV)-1 in China. The transmission dynamics of CRF01_AE, a predominant subtype in Shenzhen, is a good model to characterize the impact of human mobility on HIV-1 epidemic locally and nationally. We used phylodynamic and phylogeographic methods to estimate the viral transmission dynamics and migration trajectory of variable lineages based on 1,423 CRF01_AE sequences in Shenzhen sampled between 2006 and 2015. Eleven lineages of CRF01_AE were detected in Shenzhen. Of those, four main lineages originated during the 1990s. Their basic viral reproduction number (R
0 ) ranged 1.96–3.92. The effective viral reproduction number (Re ) of two lineages prevalent among heterosexuals/people who inject drugs had reduced <1 at the end of sampling, and the main sources were the intra-provincial immigrants (72 per cent) for one and local residents of Shenzhen (91 per cent) for another. Within two lineages among men who have sex with men (MSM), Re had been above or close to 1 at the end of sampling, and the immigrants from Jiangxi/Shaanxi and Hubei as sources accounted for 93 per cent and 68 per cent of all viral migration events, respectively. Moreover, no obvious recipients were found throughout the viral migration history for any lineage. Our findings demonstrate that HIV epidemic is declining in Shenzhen, which coincided with the initiation of the interventions during the 2000s. However, the obvious differences of the epidemic patterns between lineages emphasize the importance of further targeting interventions and continued molecular tracing, focusing on high-risk transmission sources among MSM. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
37. Bacterial Sexually Transmitted Infection Incidence Among Southern Men Who Have Sex With Men With Human Immunodeficiency Virus in the Treatment as Prevention Era, 2014–2019.
- Author
-
Gravett, Ronnie M, Cleveland, John D, Overton, Edgar T, and Marrazzo, Jeanne
- Subjects
- *
EPIDEMIOLOGY of sexually transmitted diseases , *HIV-positive persons , *ACQUISITION of data , *RETROSPECTIVE studies , *MEDICAL screening , *DISEASE incidence , *SEXUALLY transmitted diseases , *PREVENTIVE health services , *MEDICAL records , *DESCRIPTIVE statistics , *BACTERIAL diseases , *MEN who have sex with men , *VIROLOGY , *LONGITUDINAL method - Abstract
In this retrospective analysis of men who have sex with men with human immunodeficiency virus (HIV) in the South from 2014 through 2019, incident bacterial sexually transmitted infections (STIs) increased regardless of virologic control. Clinicians should prioritize STI screening and management in primary HIV care. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
38. Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.
- Author
-
Marzinke, Mark A, Grinsztejn, Beatriz, Fogel, Jessica M, Piwowar-Manning, Estelle, Li, Maoji, Weng, Lei, McCauley, Marybeth, Cummings, Vanessa, Ahmed, Shahnaz, Haines, Casey D, Bushman, Lane R, Petropoulos, Christos, Persaud, Deborah, Adeyeye, Adeola, Kofron, Ryan, Rinehart, Alex, Clair, Marty St, Rooney, James F, Pryluka, Daniel, and Coelho, Lara
- Subjects
- *
HIV , *TRANSGENDER people , *HIV prevention , *PNEUMOCYSTIS pneumonia , *HIV infections , *MEN who have sex with men - Abstract
Background: The HIV Prevention Trials Network (HPTN) 083 trial demonstrated that long-acting cabotegravir (CAB-LA) was more effective than tenofovir disoproxil fumarate-emtricitabine (TDF/FTC) in preventing human immunodeficiency virus (HIV) in cisgender men and transgender women who have sex with men. We characterized HIV infections that occurred in the blinded phase of HPTN 083.Methods: Retrospective testing included HIV testing, viral load testing, quantification of study drugs, and HIV drug resistance testing.Results: Fifty-eight infections were evaluated, including 51 incident infections (12 in CAB arm and 39 in TDF/FTC arm). In many cases (5 in CAB arm and 37 in TDF/FTC arm), infection was associated with low or unquantifiable study drug concentrations. In 4 cases, infection occurred with on-time CAB-LA injections and expected plasma CAB concentrations. CAB exposure was associated with prolonged viral suppression and delayed antibody expression. In some cases, delayed HIV diagnosis resulted in CAB provision to participants with undetected infection, delayed antiretroviral therapy, and emergence of drug resistance; most of these infections would have been detected earlier with viral load testing.Conclusions: Early detection of HIV infection and prompt antiretroviral therapy initiation could improve clinical outcomes in persons who become infected despite CAB-LA prophylaxis. Further studies are needed to elucidate the correlates of HIV protection in persons receiving CAB-LA. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
39. Social Media–Based Secondary Distribution of Human Immunodeficiency Virus/Syphilis Self-testing Among Chinese Men Who Have Sex with Men.
- Author
-
Wu, Dan, Zhou, Yi, Yang, Nancy, Huang, Shanzi, He, Xi, Tucker, Joseph, Li, Xiaofeng, Smith, Kumi M, Ritchwood, Tiarney, Jiang, Xiaohui, Liu, Xuan, Wang, Yehua, Huang, Wenting, Ong, Jason, Fu, Hongyun, Bao, Huanyu, Pan, Stephen, Dai, Wencan, and Tang, Weiming
- Subjects
- *
DIAGNOSIS of syphilis , *DIAGNOSIS of HIV infections , *HOME diagnostic tests , *SOCIAL media , *MEDICAL screening , *FISHER exact test , *DESCRIPTIVE statistics , *CHI-squared test , *MEN who have sex with men , *DATA analysis software , *PATIENT self-monitoring - Abstract
Background Social media and secondary distribution (distributing self-testing kits by indexes through their networks) both show strong promise to improve human immunodeficiency virus (HIV) self-testing uptake. We assessed an implementation program in Zhuhai, China, which focused on the secondary distribution of HIV/syphilis self-test kits among men who have sex with men (MSM) via social media. Methods Men aged ≥16 years, born biologically male, and ever had sex with another man were recruited as indexes. Banner ads on a social media platform invited the participants to apply for up to 5 self-test kits every 3 months. Index men paid a deposit of US$15/kit refundable upon submitting a photograph of a completed test result via an online submission system. They were informed that they could distribute the kits to others (referred to as "alters"). Results A total of 371 unique index men applied for 1150 kits (mean age, 28.7 [standard deviation, 6.9] years), of which 1141 test results were returned (99%). Among them, 1099 were valid test results; 810 (74%) were from 331 unique index men, and 289 tests (26%) were from 281 unique alters. Compared to index men, a higher proportion of alters were naive HIV testers (40% vs 21%; P <.001). The total HIV self-test reactivity rate was 3%, with alters having a significantly higher rate than indexes (5% vs 2%; P =.008). A total of 21 people (3%) had a reactive syphilis test result. Conclusions Integrating social media with the secondary distribution of self-test kits may hold promise to increase HIV/syphilis testing coverage and case identification among MSM. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
40. Serological Responses to Toxoplasma gondii and Matrix Antigen 1 Predict the Risk of Subsequent Toxoplasmic Encephalitis in People Living With Human Immunodeficiency Virus (HIV).
- Author
-
Xiao, Jianchun, Bhondoekhan, Fiona, Seaberg, Eric C, Yang, Otto, Stosor, Valentina, Margolick, Joseph B, Yolken, Robert H, and Viscidi, Raphael P
- Subjects
- *
ENCEPHALITIS , *HIV-positive persons , *RESEARCH , *IMMUNOGLOBULINS , *CONFIDENCE intervals , *SEROLOGY , *TOXOPLASMOSIS , *CASE-control method , *MEDICAL cooperation , *HIV seroconversion , *ODDS ratio , *MEN who have sex with men , *ANTIGENS , *DISEASE risk factors - Abstract
Background Clinically useful predictors for fatal toxoplasmosis are lacking. We investigated the value of serological assays for antibodies to whole Toxoplasma antigens and to peptide antigens of the Toxoplasma cyst matrix antigen 1 (MAG1), for predicting incident toxoplasmic encephalitis (TE) in people living with human immunodeficiency virus (HIV; PLWH). Methods We performed a nested case control study, conducted within the Multicenter AIDS Cohort Study (MACS), using serum samples obtained 2 years prior to diagnosis of TE from 28 cases, and 37 HIV disease-matched Toxoplasma seropositive controls at matched time-points. Sera were tested for Toxoplasma antibodies using a commercial assay and for antibodies to MAG1_4.2 and MAG1_5.2 peptides in enzyme-linked immunosorbent assay (ELISA). Results Two years prior to clinical diagnosis, 68% of TE cases were MAG1_4.2 seropositive compared with 16% of controls (odds ratio [OR] 25.0, 95% confidence interval [CI] 3.14–199.18). Corresponding results for MAG1_5.2 seropositivity were 36% and 14% (OR 3.6, 95% CI.95–13.42). Higher levels of antibody to MAG1_4.2 (OR 18.5 per doubling of the optical density [OD] value, 95% CI 1.41–242) and to Toxoplasma (OR 2.91 for each OD unit increase, 95% CI 1.48–5.72) were also associated with the risk of TE. When seropositivity was defined as the presence of MAG1 antibody or relatively high levels of Toxoplasma antibody, the sensitivity was 89% and specificity was 68% for subsequent TE. Conclusions Antibodies to MAG1 showed predictive value on the occurrence of TE in PLWH, and the predictive performance was further improved by adding the levels of Toxoplasma antibody. These measures could be clinically useful for predicting subsequent diseases in multiple at-risk populations. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
41. HIV Prevention Trials Network 078: High Prevalence of Hepatitis C Virus Antibodies Among Urban US Men Who Have Sex With Men, Independent of Human Immunodeficiency Virus Status.
- Author
-
Irvin, Risha, Gamble, Theresa, Malone, Jowanna, Wang, Zhe, Wilson, Ethan, Hughes, James P, Farley, Jason, Mayer, Kenneth H, Rio, Carlos Del, Batey, D Scott, Cummings, Vanessa, Remien, Robert H, Beyrer, Chris, and Thio, Chloe L
- Subjects
- *
HIV infection complications , *IMMUNOGLOBULINS , *SUBSTANCE abuse , *COUNSELING , *CONFIDENCE intervals , *MULTIPLE regression analysis , *MULTIVARIATE analysis , *HEPATITIS C , *MEDICAL screening , *PUBLIC housing , *DISEASE prevalence , *DESCRIPTIVE statistics , *MEN who have sex with men , *ODDS ratio , *PREVENTIVE medicine , *HIV - Abstract
Background Sexual transmission of hepatitis C virus (HCV) is uncommon, yet documented among men who have sex with men (MSM), primarily among those with human immunodeficiency virus (HIV). Methods In the HIV Prevention Trials Network 078 study (HPTN 078), which assessed an integrated strategy to achieve HIV viral suppression, 1305 MSM were screened across 4 geographically diverse US cities. At screening, demographic/behavioral/psychosocial questionnaires were completed, along with HIV and HCV testing. Multivariable logistic regression was used to evaluate associations with HCV antibody positivity. Results Among the 1287 (99%) of the MSM with HCV antibody results, the median age was 41, 69% were black, 85% had a high school education or more, 35% were employed, 70% had HIV, and 21% had undergone substance use counseling. The median lifetime number of male sexual partners was 17 (interquartile range, 6–50), and 246 (19%) were HCV antibody positive. HCV antibody positivity was high in MSM with HIV (20%) and MSM without HIV (17%) (P =.12) and was higher in those receiving substance use counseling (36%) than in those who had not (15%) (P ≤.01). Substance use counseling (odds ratio, 2.51; 95% confidence interval, 1.80–3.51) and unstable housing (2.16; 1.40–3.33) were associated with HCV antibody positivity. Conclusions Nearly 1 in 5 MSM screened for HPTN 078 have been infected with HCV. The prevalence is high regardless of HIV status and is high even in those who did not undergo substance use counseling. In HIV burden networks, high HCV infection prevalence may occur in MSM without HIV. As implementation of preexposure prophylaxis expands and condom use declines, routine HCV counseling and screening among MSM are important. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
42. High Prevalence and High Rate of Antibiotic Resistance of Mycoplasma genitalium Infections in Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Pre-exposure Prophylaxis Trial.
- Author
-
Berçot, Béatrice, Charreau, Isabelle, Rousseau, Clotilde, Delaugerre, Constance, Chidiac, Christian, Pialoux, Gilles, Capitant, Catherine, Bourgeois-Nicolaos, Nadège, Raffi, François, Pereyre, Sabine, Roy, Chloé Le, Senneville, Eric, Meyer, Laurence, Bébéar, Cécile, Molina, Jean-Michel, and Group, ANRS IPERGAY Study
- Subjects
- *
HIV prevention , *PHARYNX , *MYCOPLASMA diseases , *ANUS , *GENETIC mutation , *TETRACYCLINE , *TENOFOVIR , *DOXYCYCLINE , *DISEASE incidence , *EMTRICITABINE-tenofovir , *DISEASE prevalence , *DESCRIPTIVE statistics , *DRUG resistance in microorganisms , *MEN who have sex with men , *URINALYSIS , *POLYMERASE chain reaction - Abstract
Background Mycoplasma genitalium (MG) is an emerging pathogen among men who have sex with men (MSM) with raising rates of antibiotic resistance. This study assessed the prevalence and incidence of MG infection in MSM enrolled in the open-label phase of the ANRS IPERGAY trial with on-demand tenofovir disoproxil fumarate/emtricitabine for human immunodeficiency virus prevention and the impact of doxycycline post-exposure prophylaxis (PEP). Methods 210 subjects were tested at baseline and at 6 months by real-time PCR assays for MG detection in urine samples and oropharyngeal and anal swabs. Resistance to azithromycin (AZM), to fluoroquinolones (FQs), and to doxycycline was investigated in the French National Reference Center of Bacterial Sexually Transmitted Infections (STIs). Results The all-site prevalence of MG at baseline was 10.5% (6.3% in urine samples, 4.3% in anal swabs, 0.5% in throat swabs) and remained unchanged at 6 months whether or not PEP was used: 9.9% overall, 10.2% with PEP, 9.6% without. The overall rate of MG resistance (prevalent and incident cases) to AZM and FQs was 67.6% and 9.1%, respectively, with no difference between arms. An in vivo mutation of the MG 16S rRNA, which could be associated with tetracycline resistance, was observed in 12.5% of specimens tested. Conclusions The prevalence of MG infection among MSM on pre-exposure prophylaxis was high and its incidence was not decreased by doxycycline prophylaxis with a similar high rate of AZM and FQ resistance, raising challenging issues for the treatment of this STI and supporting current recommendations to avoid testing or treatment of asymptomatic MG infection. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
43. Dynamics and Dispersal of Local Human Immunodeficiency Virus Epidemics Within San Diego and Across the San Diego–Tijuana Border.
- Author
-
Vrancken, Bram, Mehta, Sanjay R, Ávila-Ríos, Santiago, García-Morales, Claudia, Tapia-Trejo, Daniela, Reyes-Terán, Gustavo, Navarro-Álvarez, Samuel, Little, Susan J, Hoenigl, Martin, Pines, Heather A, Patterson, Thomas, Strathdee, Steffanie A, Smith, Davey M, Dellicour, Simon, and Chaillon, Antoine
- Subjects
- *
HIV infection transmission , *HEALTH policy , *HIV-positive persons , *PHYLOGENY , *PUBLIC health , *EPIDEMICS , *MEN who have sex with men - Abstract
Background Evolutionary analyses of well-annotated human immunodeficiency virus (HIV) sequence data can provide insights into viral transmission patterns and associated factors. Here, we explored the transmission dynamics of the HIV-1 subtype B epidemic across the San Diego (US) and Tijuana (Mexico) border region to identify factors that could help guide public health policy. Methods HIV pol sequences were collected from people with HIV in San Diego County and Tijuana between 1996–2018. A multistep phylogenetic approach was used to characterize the dynamics of spread. The contributions of geospatial factors and HIV risk group to the local dynamics were evaluated. Results Phylogeographic analyses of the 2034 sequences revealed an important contribution of local transmission in sustaining the epidemic, as well as a complex viral migration network across the region. Geospatial viral dispersal between San Diego communities occurred predominantly among men who have sex with men, with central San Diego being the main source (34.9%) and recipient (39.5%) of migration events. HIV migration was more frequent from San Diego county towards Tijuana than vice versa. Migrations were best explained by the driving time between locations. Conclusions The US-Mexico border may not be a major barrier to the spread of HIV, which may stimulate coordinated transnational intervention approaches. Whereas a focus on central San Diego has the potential to avert most spread, the substantial viral migration independent of central San Diego shows that county-wide efforts will be more effective. Combined, this work shows that epidemiological information gleaned from pathogen genomes can uncover mechanisms that underlie sustained spread and, in turn, can be a building block of public health decision-making. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
44. A Treatment-as-Prevention Trial to Eliminate Hepatitis C Among Men Who Have Sex With Men Living With Human Immunodeficiency Virus (HIV) in the Swiss HIV Cohort Study.
- Author
-
Braun, Dominique L, Hampel, Benjamin, Ledergerber, Bruno, Grube, Christina, Nguyen, Huyen, Künzler-Heule, Patrizia, Shah, Cyril, Salazar-Vizcaya, Luisa, Conen, Anna, Flepp, Markus, Stöckle, Marcel, Béguelin, Charles, Schmid, Patrick, Rougemont, Mathieu, Delaloye, Julie, Bernasconi, Enos, Nicca, Dunja, Böni, Jürg, Rauch, Andri, and Kouyos, Roger D
- Subjects
- *
RNA analysis , *HEPATITIS C prevention , *HIV infections , *CONFIDENCE intervals , *ANTIVIRAL agents , *MEDICAL screening , *MEN who have sex with men - Abstract
Background In 2016, the World Health Organization (WHO) introduced global targets for the elimination of hepatitis C virus (HCV) by 2030. We conducted a nationwide HCV micro-elimination program among men who have sex with men (MSM) living with human immunodeficiency virus (HIV) from the Swiss HIV Cohort Study (SHCS) to test whether the WHO goals are achievable in this population. Methods During phase A (10/2015–06/2016), we performed a population-based and systematic screening for HCV-RNA among MSM from the SHCS. During phase B (06/2016–02/2017) we offered treatment with HCV direct-acting antiviral (DAA) agents to MSM identified with a replicating HCV infection. During phase C (03/2017–11/2017), we offered rescreening to all MSM for HCV-RNA and initiated DAA treatment in MSM with replicating infections. Results We screened 3715/4640 (80%) MSM and identified 177 with replicating HCV infections (4.8%); 150 (85%) of whom started DAA treatment and 149 (99.3%) were cured. We rescreened 2930/3538 (83%) MSM with a prior negative HCV-RNA and identified 13 (0.4%) with a new HCV infection. At the end of the micro-elimination program, 176/190 MSM (93%) were cured, and the HCV incidence rate declined from.53 per 100 patient-years (95% CI,.35–.83) prior to the intervention to.12 (95% CI,.03–.49) by the end of 2019. Conclusions A systematic, population-based HCV micro-elimination program among MSM living with HIV was feasible and resulted in a strong decline in HCV incidence and prevalence. Our study can serve as a model for other countries aiming to achieve the WHO HCV elimination targets. Clinical Trials Registration NCT02785666. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
45. Gaps in Sexually Transmitted Infection Screening Among Men who Have Sex with Men in Pre-exposure Prophylaxis (PrEP) Care in the United States.
- Author
-
Chandra, Christina, Weiss, Kevin M, Kelley, Colleen F, Marcus, Julia L, and Jenness, Samuel M
- Subjects
- *
PREVENTION of sexually transmitted diseases , *HIV prevention , *HEALTH policy , *CONFIDENCE intervals , *MEN'S health , *MEDICAL screening , *REGRESSION analysis , *SURVEYS , *DISEASE prevalence , *DESCRIPTIVE statistics , *MEN who have sex with men , *PREVENTIVE medicine - Abstract
Background The US Centers for Disease Control and Prevention (CDC) recommends comprehensive sexually transmitted infection (STI) screening every 3–6 months for men who have sex with men (MSM) using human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP). The gaps between these recommendations and clinical practice by region have not been quantified. Methods We used survey data collected from the internet-based ARTnet study between 2017 and 2019 on STI screening among MSM across the United States, stratified by current, prior, and never PrEP use. Poisson regression models with robust error variance were used to model factors, including residence in the Southeast, associated with consistent ("always" or "sometimes") exposure site-specific STI screening during PrEP care. Results Of 3259 HIV-negative MSM, 19% were currently using PrEP, 6% had used PrEP in the past, and 75% had never used PrEP. Among ever PrEP users, 87%, 78%, 57%, and 64% reported consistent screening for STIs by blood sample, urine sample or urethral swab, rectal swab, or pharyngeal swab, respectively, during PrEP care. Compared to PrEP users in all other regions, PrEP users in the Southeast were significantly less likely to be consistently screened for urogenital (adjusted prevalence ratio [aPR], 0.86; 95% confidence interval [CI],.76–.98) and rectal STIs (aPR, 0.76; 95% CI,.62–.93) during PrEP care. Conclusions Substantial gaps exist between CDC recommendations for STI screening during PrEP care and current clinical practice, particularly for rectal and pharyngeal exposure sites that can harbor asymptomatic infections and for MSM in Southeast states where the STI burden is substantial. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
46. Exploiting the Microbiota for the Diagnosis of Anal Precancerous Lesions in Men Who Have Sex With Men.
- Author
-
Ron, Raquel, Cabello, Alfonso, Gosalbes, María José, Sánchez-Conde, Matilde, Talavera-Rodríguez, Alba, Zamora, Javier, Monge-Maillo, Begoña, Jiménez, Daniel, Martínez-Sanz, Javier, López, Yolanda, Crespillo, Clara, Velasco, Tamara, Moreno, Santiago, Pérez-Molina, José A, and Serrano-Villar, Sergio
- Subjects
- *
ANAL cancer , *MEN who have sex with men , *FECAL microbiota transplantation , *HUMAN microbiota , *PRECANCEROUS conditions , *RECEIVER operating characteristic curves , *FISHER discriminant analysis , *DIAGNOSIS of HIV infections , *RESEARCH , *ANUS , *MICROBIOLOGY , *PHENOMENOLOGICAL biology , *RESEARCH methodology , *EVALUATION research , *ANAL tumors , *HOMOSEXUALITY , *FECES , *COMPARATIVE studies , *RESEARCH funding - Abstract
Background: While the microbiota has been associated with human papillomavirus malignant transformation, it is unclear whether anal bacteria could improve the low specificity of anal cytology for the screening of high-grade intraepithelial squamous neoplasia (HSIL).Methods: We recruited men who have sex with men undergoing anal cytology and high-resolution anoscopy. We assessed the microbiota composition from fecal samples and cytobrush anal samples using 16S ribosomal DNA sequencing in participants with or without biopsy-proven HSIL (bHSIL). We selected bacterial biomarkers based on their linear discriminant analysis. We assessed their predictive performance using logistic regression and bootstrap resampling.Results: We included 128 individuals, 47 (36.7%) with bHSIL and 99 (77.3%) with human immunodeficiency virus. We detected 40 potential predictors of bHSIL. Ruminococcaceae NK4A214 group, Alloprevotella genus, Prevotella melanonigenica, and Ruminococcaceae UCG-014 were the most predictive of bHSIL. From 35 false-positive cytologic results, the combination of these 4 biomarkers with the anal cytology reclassified to true-negative 33 individuals (94%) and showed good diagnostic performance (area under the receiver operating characteristic curve, 0.805; 95% confidence interval, .728-.882).Conclusions: We found anal-associated bacteria indicative of a higher risk of precancerous anal lesions, which combination was highly specific. The microbiota could be developed as a complementary diagnostic tool to overcome the limitations of the current screening strategy for anal cancer. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
47. Human Immunodeficiency Virus (HIV)-Negative Men Who Have Sex With Men Have Higher CD8+ T-Cell Counts and Lower CD4+/CD8+ T-Cell Ratios Compared With HIV-Negative Heterosexual Men.
- Author
-
Verboeket, Sebastiaan O, Wit, Ferdinand W, Verheij, Eveline, Zoest, Rosan A van, Kootstra, Neeltje A, van der Valk, Marc, Prins, Jan M, Loeff, Maarten F Schim van der, Reiss, Peter, Group, AGEhIV Study, van Zoest, Rosan A, Schim van der Loeff, Maarten F, and AGEhIV Study Group
- Subjects
- *
MEN who have sex with men , *HIV , *T cells , *HETEROSEXUAL men , *SEXUALLY transmitted diseases - Abstract
Background: We previously reported T-cell senescence to be similar in people with human immunodeficiency virus (PWH) with suppressed viremia (predominantly men who have sex with men [MSM]) and human immunodeficiency virus (HIV)-negative otherwise comparable controls but greater than in healthy blood donors. This led us to compare CD4+ and CD8+ T-cell counts and CD4+/CD8+ ratios between HIV-negative MSM and men who only have sex with women (MSW) and relate observed differences in behavioral factors and infectious exposures, including cytomegalovirus (CMV) infection.Methods: In 368 HIV-negative MSM and 72 HIV-negative MSW, T lymphocyte phenotyping was performed 3 times biennially. Baseline CMV serology and sexually transmitted infection (STI) incidence and/or STI seroprevalence, sexual, and substance-use behavior data were collected during study visits.Results: Men who have sex with men, compared with MSW, had higher CD8+ counts (551 vs 437 cells/mm3, P < .001), similar CD4+ counts (864 vs 880 cells/mm3, P = .5), and lower CD4+/CD8+ ratios (1.84 vs 2.47, P < .001). Differences were most pronounced for MSM with >10 recent sex partners and partly explained by higher CMV seroprevalence in MSM.Conclusions: These findings suggest that factors other than HIV may, in both PWH and certain HIV-negative MSM, contribute to a low CD4+/CD8+ ratio. Whether this, like in PWH, contributes to comorbidity risk in HIV-negative MSM requires further study. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
48. Effective Treatment of Lymphogranuloma venereum Proctitis With Azithromycin.
- Author
-
Blanco, José L, Fuertes, Irene, Bosch, Jordi, Lazzari, Elisa De, Gonzalez-Cordón, Ana, Vergara, Andrea, Blanco-Arevalo, Alejandro, Mayans, Josep, Inciarte, Alexy, Estrach, Teresa, Martinez, Esteban, Cranston, Ross D, Gatell, Josep M, and Alsina-Gibert, Merce
- Subjects
- *
LYMPHOGRANULOMA venereum , *CEFTRIAXONE , *REVERSE transcriptase polymerase chain reaction , *CLINICAL trials , *RECTAL diseases , *ORAL drug administration , *DOXYCYCLINE , *TREATMENT effectiveness , *AZITHROMYCIN , *MEN who have sex with men , *STATISTICAL sampling , *POLYMERASE chain reaction , *HIV - Abstract
Background Lymphogranuloma venereum (LGV) is a sexually transmitted infection caused by Chlamydia trachomatis (CT) serovars L1, L2, and L3 and is endemic among men who have sex with men (MSM) in Europe. We evaluated weekly oral azithromycin 1 g for 3 weeks as a treatment for LGV proctitis. Methods This is an open clinical trial with convenience allocation according to treating physician preferences. Adults with clinical proctitis received a single dose of 1 g of intramuscular ceftriaxone and were subsequently allocated to receive (i) doxycycline 100 mg twice daily for 21 days (Doxycycline group) or (ii) azithromycin 1 g orally once weekly for 3 weeks (Azithromycin group). LGV cure (primary endpoint) was defined as resolution of symptoms at week 6 (clinical cure, LGV-CC), with an additional supporting negative rectal polymerase chain reaction (PCR) at week 4 (microbiological cure, LGV-MC), if available. Results One hundred and twenty-five individuals with LGV clinical proctitis were included. All were MSM, and 96% were living with human immunodeficiency virus (HIV). Eighty-two were in the Azithromycin group, and 43 were in the Doxycycline group. LGV cure on a modified intention-to-treat analysis (primary endpoint), occurred in 80 of 82 (98%) in the Azithromycin group versus 41 of 43 (95%) in the Doxycycline group (treatment difference [95% confidence interval {CI}] 2.2% [−3.2, 13.2]). LGV-MC occurred in 70 of 72 (97%) vs 15 of 15 (100%) in the Azithromycin group and Doxycycline group, respectively (treatment difference [95% CI] −2.8% [−9.6; 17.7]). Adverse events were similar in both treatment groups. Conclusions Our findings support extended azithromycin dosing as an alternative treatment option for symptomatic LGV proctitis and provides the rationale for future randomized trials. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
49. Prevalence of Gastrointestinal Pathogens Detected by Multiplex Polymerase Chain Reaction in a Prospective Cohort of Men Who Have Sex With Men Taking Human Immunodeficiency Virus Preexposure Prophylaxis—New York City, 2019–2020.
- Author
-
Purpura, Lawrence, Zucker, Jason, LaSota, Elijah, Lopez, Mabel, Spicehandler, Rebecca, Carnevale, Caroline, Perez, Edward, Richards, Paul, Chang, Jennifer, Cohall, Al, Uhlemann, Anne-Catrin, Whittier, Susan, Sobieszczyk, Magdalena E, and Green, Daniel A
- Subjects
- *
HIV , *POLYMERASE chain reaction , *PATHOGENIC microorganisms , *PREVENTIVE medicine - Abstract
Multiplex polymerase chain reaction testing for gastrointestinal pathogens was performed on a longitudinal cohort of 110 men who have sex with men taking human immunodeficiency virus preexposure prophylaxis. At least 1 pathogen was detected among 50 (45%) participants, with some participants testing positive for the same pathogen on multiple consecutive visits over a period of months. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
50. Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide for Human Immunodeficiency Virus Preexposure Prophylaxis at a Boston Community Health Center.
- Author
-
Marcus, Julia L, Levine, Kenneth, Sewell, Whitney C, Solleveld, Patricia, Mayer, Kenneth H, and Krakower, Douglas S
- Subjects
- *
HIV , *COMMUNITY centers , *TENOFOVIR , *MEDICAL centers , *CARDIOVASCULAR diseases risk factors - Abstract
Background Efforts to end the human immunodeficiency virus (HIV) epidemic may be threatened if limited preexposure prophylaxis (PrEP) resources are funneled from tenofovir disoproxil fumarate with emtricitabine (TDF/FTC) to tenofovir alafenamide with emtricitabine (TAF/FTC) without proportional clinical benefits. Methods The study population was patients at a Boston community health center who were assigned male sex at birth, aged ≥18 years, and prescribed TDF/FTC for PrEP in the 12 months before TAF/FTC approval (October 2019). We determined the frequency of switching to TAF/FTC in the 12 months after approval, including clinically indicated switching (ie, creatinine clearance <60 mL/minute or reduced bone density), potentially unnecessary switching (ie, no indications for switching and no cardiovascular risk factors), and potentially harmful switching (ie, no indications for switching and either obesity or dyslipidemia). Results Of 2892 TDF/FTC users, mean age was 38 years, 96.0% were cisgender men, and 78.9% were white. A total of 343 (11.9%) switched to TAF/FTC. Based on documented renal, bone, and cardiovascular risk factors, we identified 24 (7.0%) with clinically indicated switching, 271 (79.0%) with potentially unnecessary switching, and 48 (14.0%) with potentially harmful switching. When indications for switching additionally included hypertension, diabetes, and creatinine clearance 60–70 mL/minute, 27.1% of switching was clinically indicated. Conclusions Few who switched to TAF/FTC had documented indications for switching, although some appear to have been switched in anticipation of indications developing. As generic TDF/FTC is further discounted, provider education and patient decision aids are needed to facilitate selection of PrEP medications that is both clinically sound and cost-effective. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.